Advanced search
Publication Cover
Journal of Medical Economics Volume 13, 2010 - Issue 3
Submit an article Journal homepage
1,639
Views
16
CrossRef citations to date
0
Altmetric
Review Article

Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidence

Josephine A. Mauskopf RTI Health Solutions, RTP, NC, USACorrespondence[email protected]
,
Christine L. Baker MPH, Pfizer Inc, New York, NY, USA
,
Brigitta U. Monz Boehringer Ingelheim International GmbH, Ingelheim, Germany
&
Melissa D. Juniper RTI Health Solutions, RTP, NC, USA
Pages 403-417 | Accepted 07 Jun 2010, Published online: 08 Jul 2010

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Luigino Calzetta, Chiara Ciaprini, Ermanno Puxeddu & Mario Cazzola. (2016) Olodaterol + tiotropium bromide for the treatment of COPD. Expert Review of Respiratory Medicine 10:4, pages 379-386.
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2015) Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 8:5, pages 529-539.
Read now
Giorgio L Colombo, Daria Bettoni, Sergio Di Matteo, Camilla Grumi, Cinzia Molon, Daniela Spinelli, Gaetano Mauro, Alessia Tarozzo & Giacomo M Bruno. (2014) Economic and outcomes consequences of TachoSil®: a systematic review. Vascular Health and Risk Management 10, pages 569-576.
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2014) Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 15:7, pages 961-977.
Read now

Articles from other publishers (12)

Oskar Eklund, Faraz Afzal & Fredrik Borgström. (2015) Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden. Cost Effectiveness and Resource Allocation 13:1.
Crossref
Charlotta Karner, Jimmy Chong & Phillippa Poole. (2014) Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2016:11.
Crossref
Timothy H Harries, Paul T Seed, Simon Jones, Peter Schofield & Patrick White. (2014) Chronic obstructive pulmonary disease hospital admissions and drugs—unexpected positive associations: a retrospective general practice cohort study. npj Primary Care Respiratory Medicine 24:1.
Crossref
Steven Simoens. (2013) Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review. Journal of Evaluation in Clinical Practice 19:6, pages 1004-1011.
Crossref
Max Brosa-Riestra, Ferran Pérez-Alcántara, Luis Borderías-Clau, Juan Bautista Galdiz-Iturri, Maribel Riera-Febrer & Montse Figueras-Sabaté. (2013) Análisis de coste-utilidad de indacaterol frente a tiotropio en el tratamiento de la EPOC en España. PharmacoEconomics Spanish Research Articles 10:3, pages 89-97.
Crossref
María Buti, Itziar Oyagüez, Virginia Lozano & Miguel A. Casado. (2012) Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B. PharmacoEconomics 31:1, pages 63-75.
Crossref
Robert Hettle, Hanne Wouters, Jon Ayres, Ray Gani, Steve Kelly, Michaela Lion & Marc Decramer. (2012) Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium. Respiratory Medicine 106:12, pages 1722-1733.
Crossref
Klaus F. Rabe. (2012) Drug Safety in COPD Revisited. Chest 142:2, pages 271-274.
Crossref
Charlotta Karner, Jimmy Chong & Phillippa Poole. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Javier Soto ÁlvarezJavier Soto Álvarez. 2012. Evaluación económica de medicamentos y tecnologías sanitarias:. Evaluación económica de medicamentos y tecnologías sanitarias: 277 292 .
Charlotta Karner, Jimmy Chong & Phillippa Poole. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Colin R. Dormuth, Richard L. Morrow & Greg Carney. (2011) Trends in Health Care Utilization in British Columbia Following Public Coverage for Tiotropium. Value in Health 14:4, pages 600-606.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.